Latab, Nanie S.

HRN: 13-82-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2023
CEFTAZIDIME 1GM (VIAL)
12/03/2023
12/10/2023
IV
1 Gram
Q8H
CAP MR; T/C TB Bronchiectasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: No 

Intervention



Type of Intervention done:

                    

           


Acceptance: